About Mepolizumab
            
            Class: | Monoclonal antibody (IL-5 antagonist)  
Use: | Treatment of severe asthma with eosinophilic phenotype, eosinophilic granulomatosis with polyangiitis (EGPA), and chronic rhinosinusitis with nasal polyps (CRSwNP)  
Adult dose: | 100 mg subcutaneously once every 4 weeks  
Pediatric dose: | For patients aged 6 years and older with severe asthma, 40 mg subcutaneously once every 4 weeks; for patients weighing 40 kg or more, 100 mg subcutaneously once every 4 weeks  
Side effects: | Headache, 
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (IL-5 antagonist)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of severe asthma with eosinophilic phenotype, eosinophilic granulomatosis with polyangiitis (EGPA), and chronic rhinosinusitis with nasal polyps (CRSwNP)
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator at 2°C to 8°C (36°F to 46°F); do not freeze; may be stored at room temperature (up to 25°C or 77°F) for a maximum of 7 days
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: GlaxoSmithKline Trading Services Limited, IRELAND
                    
                    
                    Package Size
                    100 MG PEN
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 5821.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        100 mg subcutaneously once every 4 weeks
                    
                    
                        Pediatric Dose
                    
                    
                        For patients aged 6 years and older with severe asthma, 40 mg subcutaneously once every 4 weeks; for patients weighing 40 kg or more, 100 mg subcutaneously once every 4 weeks
                    
                 
                
                
                    
                        Side Effects
                    
                    Headache, injection site reactions, back pain, fatigue, and abdominal pain
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to mepolizumab or any of its components; caution in patients with a history of hypersensitivity reactions
         
        
        
            
                Important Warnings
            
            Risk of serious allergic reactions; monitor for signs of anaphylaxis; not indicated for the treatment of acute asthma exacerbations or for the treatment of other allergic conditions; may increase the risk of herpes zoster infection
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.